Karnataka HC stays FSSAI curb on Ashwagandha, relief for Kerry, Sami-Sabinsa & 6 others
The Karnataka High Court has stayed FSSAI's April 16 advisory restricting use of Ashwagandha leaves in food and health supplements, granting interim relief to eight companies including US-based Kerry Inc and Sami-Sabinsa. Petitioners argued FSSAI overstepped by curbing a 30-year-old supplement ingredient via advisory without amending regulations. Next hearing June 8.
What happened
Karnataka HC stayed an FSSAI advisory restricting Ashwagandha leaves in food and health supplements, granting interim relief to eight companies including Kerry
Key facts
- 8 companies
- 30 years
- April 16 advisory
- June 8 hearing
Why this matters
Valuations of Ashwagandha-exposed ingredient and supplement targets should rebound on the stay, opening a tactical window to negotiate deals before June 8 clarity potentially re-rates the category.